Comparative study of bcs based biowaiver approaches and current developments towards harmonization
Biowaiver on the basis of BCS is an important tool for pharmaceutical
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Biowaiver on the basis of BCS is an important tool for pharmaceutical
In principle, drug dissolution testing should be one of the simplest analytical
Simvastatin is classified as a biopharmaceutics classification system class II drug. Emulgel is a superior alternative for biopharmaceutics classification system class II drugs with low solubility and high permeability
scientific system for classifying drug substance based upon their aqueous solubility as related to dose and permeability. The BCS is guiding for prediction of in vivo performance of the drug ... oral bioavailability of…
experiments have been successfully employed to replace clinical bioequivalence according to the Biopharmaceutics Classification System (BCS) for immediate release solid oral dosage forms. However, as drug products…
project was to formulate rectal pediatric forms. Ceftriaxone belongs to Biopharmaceutical classification System (BCS) classe 3, meaning that it is well soluble, but weakly permeable. Furthermore, it is described
present impacts of the Biopharmaceutics Classification System (BCS) and Biopharmaceutics Drug Disposition Classification System (BDDCS) on pertinent scientific advancements are discussed. The detailed study of the…
assembled nanostructures for hydrophobic drugs, and stimuli-responsive systems for controlled release. The biopharmaceutical classification system, solid-state properties, and excipients in amorphous solid dispersions…
need for in vivo assessment. The concept of biowaiver is based on the Biopharmaceutics Classification System (BCS) and evaluates the biopharmaceutical and clinical parameters of the active pharmaceutical ingredient
system. The selection criteria for floating systems involve various physicochemical characters of drug. Biopharmaceutical classification system (BCS) is vital criteria for drug to be selected. BCS classification is based
developed binary systems may apply to overcome solubility issues of biopharmaceutical classification system class II drugs. The developed formulations are easy to scale
transdermal delivery systems. IPN is highly effective for controlling the drug release of Biopharmaceutics Classification System (BCS) class I drugs
Delivery System (SMEDDS) of Furosemide. Furosemide is Class IV molecule according to BCS (Biopharmaceutical Classification System), having low solubility and low permeability. Prepared optimized SMEDDS of Furosemide…
pharmacological response. Poor water solubility of new chemical entities belonging to biopharmaceutical classification system (BCS) class II and IV accounts for 40 to 70% incidence of delay or failure during
pharma¬cological response. Poor water solubility of new chemical entities belonging to Biopharmaceutical Classification System (BCS) class II and IV accounts for 40 to 70% incidence of delay or failure
discovered active pharmaceutical ingredients (APIs) have poor water solubility, dissolution enhancement of the Biopharmaceutical Classification System (BCS) II type (poorly water-soluble, but highly permeable) drugs
Asthma is a common chronic inflammatory disorder of the airways. It is
been used as a pain reliever for a long time. However, as a Biopharmaceutics Classification System II drug, the low solubility remains a major issue. Recently an article has featured
used for the treatment of schizophrenia. It is class II drug as per Biopharmaceutical classification system (BCS). Its solubility is decreasing as the pH is increasing therefore low absorption
bioavailability is influenced by drug solubility and permeability. For drugs belonging to the biopharmaceutical classification system class II, class III, and class IV, drug encapsulation in nanocarriers provides an…
Ethosomes are amphiphilic novel lipid vesicular systems that have shown their potential in improving the bioavailability of poorly water soluble as well ... poorly lipophilic drugs. Mefenamic acid is anthranilic acid…
compounds exhibit low solubility in water, which means low oral bioavailability, associated with Biopharmaceutical Classification System class II (BCS) drugs. In recent years, much attention has been focused on emulsion
which the active ingredient or moiety becomes available at the site of action. For systemically active drug products, the AUCt , AUC∞ and Cmax of the drug plasma concentration profiles ... currently implemented BE…
medoxomil has very poor aqueous solubility and belongs to Class II drugs under Biopharmaceutical Classification Systems. The purpose of the present study was to investigate the bioavailability enhancement of olmesartan
For authors and organisers
Find the right journal for your paper and submit your manuscript.